Longevity Briefing

The Pulse

A curated daily readout of the science, companies, capital flows, and policy moves shaping longevity.

Feature09 Apr 2026

The KEANAISSANCE Summit 2026

KEANAISSANCE convenes a tightly curated group of founders, investors, clinicians, and operators in a setting designed to accelerate execution in the longevity economy. By removing the audience layer and focusing on decision-makers with direct agency, it creates an environment where capital, science, and delivery can align more quickly. The result is not just discussion, but a higher probability of real partnerships, capital deployment, and tangible progress.

Kea

More from Masters of Longevity

Longevity March

A Global Rally for Life Extension

Editorial10 Apr 2026

On April 8, the streets of Madrid were not the scene of an ordinary protest. Citizens, scientists, entrepreneurs, and healthcare professionals gathered for the Longevity March, a global mobilization that connected Madrid simultaneously with major cities such as Brussels, London, Paris, and Berlin in Europe; Caracas, Mexico City, and San Francisco in the Americas; and Abu Dhabi and Tel Aviv in the Middle East, even during the current war in the region. The message was clear and urgent: aging must be treated as a global political and scientific priority.

Cover image for Beyond the Hype: What Science Really Says About Your Gut Bacteria

Beyond the Hype: What Science Really Says About Your Gut Bacteria

Editorial09 Apr 2026

The gut microbiome has become a scientific and public fascination, with new studies and health claims emerging daily. While diet is often cited as the key factor shaping gut bacteria, research suggests a far more complex picture. With over 200 variables influencing an individual’s microbiome and only a fraction of its variability explained, the idea of a universally “healthy” gut remains elusive. Popular microbiome tests and interventions may not tell the whole story – especially when stool samples only offer a partial snapshot of the vast intestinal ecosystem. This article explores the intricate relationship between diet, microbiome diversity, and health, challenging common assumptions and highlighting the unanswered questions in this rapidly evolving field.

the-sickcare-problem2

The MoL Report - Domestic Longevity Adoption in Switzerland and The “Sick Care” Problem

Editorial30 Mar 2026

The Swiss healthcare system is frequently cited as one of the most robust, high-quality, and accessible systems in the world. However, a closer examination of its financial architecture reveals a system fundamentally misaligned with the emerging paradigm of longevity and preventive health. It’s a system optimized for “Sick Care” – the management of acute pathology and established chronic disease – but structurally fails to preserve health capital. This report dissects the structural and economic forces behind this dynamic and explores what would need to change to enable a transition toward a prevention- and longevity-driven healthcare system.

LinkedIn - Nicholas A. Gnan

What most people missed in the Medvi story is what this becomes: a blueprint for how healthcare can be drop shipped a...

Analysis argues MEDVi’s scale reflects a distribution-first business that layers paid media and customer relationships on top of outsourced clinical and fulfillment services rather than being primarily an AI play.

Why it matters This signals healthcare delivery is becoming modular, shifting competitive advantage to distribution, customer acquisition, and LTV/CAC optimization.

human-evidencelifestylepolicy
19 Apr 2026 at 07:42
Neuroscience News

3D-Printed “Honeycomb” Sensors Match Your Unique Neural Map

Researchers developed 3D-printed honeycomb hydrogel electrodes customized from MRI-based models to match individual cortical folds, yielding improved contact and signal quality without apparent tissue damage.

Why it matters Patient-specific, soft hydrogel electrodes address a major limitation of one-size-fits-all neural interfaces by improving surface contact and.

human-evidencesciencepolicy
18 Apr 2026 at 19:57
Science Daily - Health & Medicine

It doesn’t matter how much you sit — walking more could lower your risk of death and disease

A device-based cohort study of over 72,000 people found that increasing daily steps lowers mortality and cardiovascular disease risk, with peak benefits around 9,000–10,000 steps per day.

Why it matters The findings quantify a practical, low-cost behavior—walking—that substantially reduces mortality and CVD risk even for highly sedentary individuals.

high-signalscienceresearch-signal
18 Apr 2026 at 16:08
Peter Attia

Prostate cancer: a PSA on PSA

Evaluation of PSA screening trends highlights improved detection using PSA plus MRI, evidence that biparametric MRI is noninferior to multiparametric MRI, and reduced infections with transperineal biopsy.

Why it matters Findings point to practical shifts in prostate cancer screening and diagnostic workflows that affect clinical outcomes, technology adoption, and.

human-evidencesciencebiotech
18 Apr 2026 at 13:00